ArticleGene therapy2023

Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution.

Ruixin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.